Naloxone attenuates the anxiolytic action of diazepam in man

The present study addresses the possible role of endorphins in mediating the anxiolytic properties of diazepam (DZM) in man. The ability of a low dose (0.4 mg. i.v.) of the specific opiate antagonist, Naloxone (NLX) to modify the anxiolytic action of DZM (0.07 mg/kg i.v.) in 22 patients anticipating...

Full description

Saved in:
Bibliographic Details
Published inLife sciences (1973) Vol. 31; no. 16-17; p. 1833
Main Authors Duka, T, Millan, M J, Ulsamer, B, Doenicke, A
Format Journal Article
LanguageEnglish
Published Netherlands 01.01.1982
Subjects
Adult
Anxiety - drug effects
Blood Pressure - drug effects
Diazepam - pharmacology
Female
Humans
Male
Naloxone - pharmacology
Online AccessGet more information

Cover

More Information
Summary:The present study addresses the possible role of endorphins in mediating the anxiolytic properties of diazepam (DZM) in man. The ability of a low dose (0.4 mg. i.v.) of the specific opiate antagonist, Naloxone (NLX) to modify the anxiolytic action of DZM (0.07 mg/kg i.v.) in 22 patients anticipating minor orthopaedic surgery was evaluated. The study was performed in a double-blind placebo (saline)-controlled, randomized design. DZM administered 3 hours pre operation, reduced the anxiety experienced by subjects as estimated on a formal rating scale completed by the patients. NLX, as compared to saline, given 30 min post DZM significantly and strongly attenuated, but did not abolish this effect of DZM. These findings parallel observations in rats of the ability of NLX to block the action of DZM in the conflict test and suggest that the anxiolytic action of DZM in man may be partially mediated by endorphins.
ISSN:0024-3205
DOI:10.1016/0024-3205(82)90222-3